<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: relapse rates</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Patient expresses concern about lack of data on biological drugs</title>
   	 <description>(HealthDay)—A patient with Crohn's disease is concerned about the attempt by the makers of adalimumab to prevent disclosure of trial data submitted during the drug's approval process, according to a personal view piece published online April 16 in BMJ.</description>
     <link>http://medicalxpress.com/news/2013-04-patient-lack-biological-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 18 Apr 2013 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news285517875</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/patientexpre.jpg" width="90" height="90" />
</item>
<item>
     <title>A new treatment option for alcohol dependence: Reduced consumption rather than abstinence</title>
   	 <description>A potential new treatment for alcoholism called nalmefene is effective and safe for reducing alcohol consumption in alcohol dependent individuals, says a new study published this week in Biological Psychiatry.</description>
     <link>http://medicalxpress.com/news/2013-04-treatment-option-alcohol-consumption-abstinence.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Thu, 11 Apr 2013 06:02:42 EST</pubDate>
	 <guid isPermaLink="false">news284878955</guid>
	 
</item>
<item>
     <title>Combination therapy provides similar clinical benefit as single drug treatment in MS</title>
   	 <description>People with multiple sclerosis (MS) who were treated with combination therapy did not see significant clinical benefit over those treated with single drug therapy, but combination therapy did reduce the development of new lesions, according to an international research team led by The Mount Sinai Medical Center. The findings, part of the largest-ever MS trial sponsored by the National Institutes of Health, are published in the March 11 issue of Annals of Neurology.</description>
     <link>http://medicalxpress.com/news/2013-03-combination-therapy-similar-clinical-benefit.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 11 Mar 2013 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news282228386</guid>
	 
</item>
<item>
     <title>Common MS drugs taken together do not reduce relapse risk</title>
   	 <description>A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings published today in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.</description>
     <link>http://medicalxpress.com/news/2013-03-common-ms-drugs-relapse.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 11 Mar 2013 12:45:09 EST</pubDate>
	 <guid isPermaLink="false">news282224703</guid>
	 
</item>
<item>
     <title>Natalizumab shows promise for teens with multiple sclerosis</title>
   	 <description>(HealthDay)—Natalizumab may be safe in pediatric multiple sclerosis (MS) patients with highly active disease, according to a small study published online Feb. 18 in JAMA Neurology.</description>
     <link>http://medicalxpress.com/news/2013-02-natalizumab-teens-multiple-sclerosis.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Fri, 22 Feb 2013 16:10:01 EST</pubDate>
	 <guid isPermaLink="false">news280765852</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/natalizumabs.jpg" width="90" height="90" />
</item>
<item>
     <title>Study shows smoking cessation more successful for cancer patients who quit before surgery</title>
   	 <description>Lung and head and neck cancer patients who smoked before surgery are more likely to relapse than those who had quit before surgery, Moffitt Cancer Center researchers say. They found that smoking-relapse prevention interventions are needed immediately after surgery to help prevent relapse.</description>
     <link>http://medicalxpress.com/news/2013-01-cessation-successful-cancer-patients-surgery.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 23 Jan 2013 03:53:32 EST</pubDate>
	 <guid isPermaLink="false">news278135604</guid>
	 
</item>
<item>
     <title>Landmark study in blood stem cell transplant</title>
   	 <description>(Medical Xpress)—Before all the excitement about embryonic stem cells, doctors were using hematopoetic – that is, blood-forming—stem cells. Hematopoetic stem cells can replenish all the types of cells in the blood, and are the centerpiece of transplantation as treatment for diseases such as multiple myeloma or leukemia. They can come from two different places: directly from the marrow of a donor's hip bone, or indirectly from the donor's blood after a drug nudges the stem cells out of the bone marrow.</description>
     <link>http://medicalxpress.com/news/2013-01-landmark-blood-stem-cell-transplant.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 04 Jan 2013 08:20:01 EST</pubDate>
	 <guid isPermaLink="false">news276509199</guid>
	 
</item>
<item>
     <title>Hypofractionated radiotherapy was safe, effective for early breast cancer treatment at 10-year follow-up</title>
   	 <description>Appropriately dosed hypofractionated radiotherapy was gentle on healthy tissues and effective in controlling local-regional early breast cancer, according to 10-year follow-up results from the U.K. Standardization of Breast Radiotherapy Trials (START), presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium.</description>
     <link>http://medicalxpress.com/news/2012-12-hypofractionated-radiotherapy-safe-effective-early.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 07 Dec 2012 10:40:03 EST</pubDate>
	 <guid isPermaLink="false">news274095123</guid>
	 
</item>
<item>
     <title>Old habits die hard: Helping cancer patients stop smoking</title>
   	 <description>It's a sad but familiar scene near the grounds of many medical campuses: hospital-gowned patients, some toting rolling IV poles, huddled in clumps under bus shelters or warming areas, smoking cigarettes.</description>
     <link>http://medicalxpress.com/news/2012-11-habits-die-hard-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Nov 2012 12:50:15 EST</pubDate>
	 <guid isPermaLink="false">news273156596</guid>
	 
</item>
<item>
     <title>Smoking relapse prevention a healthy step for mothers, babies</title>
   	 <description>(Medical Xpress)—Researchers at Moffitt Cancer Center, concerned that women who quit smoking during their pregnancies often resume smoking after they deliver their baby, tested self-help interventions designed to prevent postpartum smoking relapse.</description>
     <link>http://medicalxpress.com/news/2012-09-relapse-healthy-mothers-babies.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 26 Sep 2012 10:24:56 EST</pubDate>
	 <guid isPermaLink="false">news267873851</guid>
	 
</item>
<item>
     <title>Multiple sclerosis drug disappoints on disability</title>
   	 <description>(Medical Xpress) -- This week the Journal of the American Medical Association published a study with unfortuate news for the millions of people who suffer from multiple sclerosis. In the large study, a therapy known as interferon beta failed to stave off the progression of the incurable disease. Albert Lo, associate professor of neurology and epidemiology, comments on what the study means for patients, why it was well-designed, and how a new effort to support research on the disease in Rhode Island could help.</description>
     <link>http://medicalxpress.com/news/2012-07-multiple-sclerosis-drug-disappoints-disability.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 23 Jul 2012 07:41:11 EST</pubDate>
	 <guid isPermaLink="false">news262248063</guid>
	 
</item>
<item>
     <title>Meds can help recovering meth addicts stay sober</title>
   	 <description>(Medical Xpress) -- A drug shown to help break alcohol addiction can also help recovering methamphetamine addicts stay clean, a study led by University of Virginia School of Medicine researcher Dr. Bankole A. Johnson has found.</description>
     <link>http://medicalxpress.com/news/2012-06-meds-recovering-meth-addicts-sober.html</link>
	 <category>Addiction</category>
	 <pubDate>Thu, 14 Jun 2012 06:29:13 EST</pubDate>
	 <guid isPermaLink="false">news258874146</guid>
	 
</item>
<item>
     <title>Antipsychotics do help many with schizophrenia, study finds</title>
   	 <description>(HealthDay) -- A new study finds that antipsychotic drugs can help many people with schizophrenia, cutting patients' risk of relapse by 60 percent.</description>
     <link>http://medicalxpress.com/news/2012-05-antipsychotics-schizophrenia.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Thu, 03 May 2012 15:20:03 EST</pubDate>
	 <guid isPermaLink="false">news255274744</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-antipsychoti.jpg" width="90" height="90" />
</item>
<item>
     <title>Cigarette pack health warnings can help ex-smokers stave off urge to resume smoking</title>
   	 <description>Health warnings on cigarette packs can help ex-smokers stave off the urge to start smoking again, indicates research published online in Tobacco Control.</description>
     <link>http://medicalxpress.com/news/2012-04-cigarette-health-ex-smokers-stave-urge.html</link>
	 <category>Addiction</category>
	 <pubDate>Wed, 25 Apr 2012 18:30:02 EST</pubDate>
	 <guid isPermaLink="false">news254592712</guid>
	 
</item>
<item>
     <title>Recovery housing and treatment programs reduce relapse among recovering opioid addicts</title>
   	 <description>Opioid-dependent individuals who want to kick the habit typically begin the road to recovery with detoxification. But detox is ineffective as a stand-alone treatment, with relapse rates ranging from 65% to 80% just one month after discharge. New research published online today in the journal Addiction reveals that individuals with substance use disorders may be as much as ten times more likely to stay abstinent when they have access to drug-free recovery housing and day-treatment programs following detox.</description>
     <link>http://medicalxpress.com/news/2012-02-recovery-housing-treatment-relapse-recovering.html</link>
	 <category>Addiction</category>
	 <pubDate>Tue, 28 Feb 2012 04:43:25 EST</pubDate>
	 <guid isPermaLink="false">news249626579</guid>
	 
</item>


</channel>
</rss>
